Chardan Capital Maintains Buy on Coya Therapeutics, Maintains $14 Price Target

County Bk Greenwood S C Com -0.39% Pre

County Bk Greenwood S C Com

COYA

7.67

7.67

-0.39%

0.00% Pre

Chardan Capital analyst Keay Nakae maintains Coya Therapeutics (NASDAQ: COYA) with a Buy and maintains $14 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via